Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020)
Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Palisade Bio | 424.57 Mn | 291.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -200.00% |
| Mar 31, 2018 | 1,225,590.20% |
| Dec 31, 2017 | -114.74% |
| Jun 30, 2016 | -101.35% |
| Mar 31, 2016 | 393.27% |
| Dec 31, 2015 | -125.56% |
| Sep 30, 2015 | 10,852.44% |
| Jun 30, 2015 | 5.45% |
| Mar 31, 2015 | -29.24% |
| Dec 31, 2014 | 20.03% |
| Sep 30, 2014 | 43.91% |
| Jun 30, 2014 | 98.89% |
| Mar 31, 2014 | -16,387.95% |
| Dec 31, 2013 | 55.42% |
| Sep 30, 2013 | -47.11% |
| Jun 30, 2013 | -45.42% |
| Mar 31, 2013 | -45.50% |
| Dec 31, 2012 | -72.27% |
| Sep 30, 2012 | 68.06% |
| Jun 30, 2012 | -320.34% |